Back to SYRE
MARSHALL WACE, LLP SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
7
Latest value
$48.4M
Q3 2026
Peak value
$48.4M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $436K |
| Q1 2024 | $6.1M |
| Q2 2026 | $17.3M |
| Q2 2026 | $33.9M |
| Q2 2026 | $36.9M |
| Q3 2026 | $15K |
| Q3 2026 | $48.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48.4M | 544.0K | — | — |
| Q3 2026 | $15K | 171 | — | — |
| Q2 2026 | $36.9M | 415.8K | — | — |
| Q2 2026 | $33.9M | 381.4K | — | — |
| Q2 2026 | $17.3M | 194.5K | — | — |
| Q1 2024 | $6.1M | 161.9K | — | — |
| Q4 2023 | $436K | 20.3K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M